Economic Evaluation in the US
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 24 (11) , 1163-1168
- https://doi.org/10.2165/00019053-200624110-00012
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Managing Biotechnology In A Network-Model Health Plan: A U.S. Private Payer PerspectiveHealth Affairs, 2006
- Emerging Lessons From The Drug Effectiveness Review ProjectHealth Affairs, 2006
- Biotech drug market steadily expandsNature Biotechnology, 2005
- Medicare and Cost-Effectiveness AnalysisNew England Journal of Medicine, 2005
- Medicare’s National Coverage Decisions, 1999–2003: Quality Of Evidence And Review TimesHealth Affairs, 2005
- Evidence Of Evidence-Based Health Policy: The Politics Of Systematic Reviews In Coverage DecisionsHealth Affairs, 2005
- Medicare Coverage for Technological Innovations — Time for New Criteria?New England Journal of Medicine, 2004
- Economic analysis in healthcare decisions.2004
- Cost-Effectiveness And Evidence Evaluation As Criteria For Coverage PolicyHealth Affairs, 2004
- Cost Effectiveness of Lung-Volume–Reduction Surgery for Patients with Severe EmphysemaNew England Journal of Medicine, 2003